ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/05/09 | 2,785 | 2,816 | 2,768 | 2,795 | +24 | +0.9% | 152,800 |
2016/05/06 | 2,755 | 2,784 | 2,731 | 2,771 | +19 | +0.7% | 329,000 |
2016/05/02 | 2,709 | 2,758 | 2,703 | 2,752 | -76 | -2.7% | 165,700 |
2016/04/28 | 2,914 | 2,930 | 2,809 | 2,828 | -75 | -2.6% | 254,100 |
2016/04/27 | 2,934 | 2,966 | 2,887 | 2,903 | -10 | -0.3% | 166,000 |
2016/04/26 | 2,896 | 2,932 | 2,878 | 2,913 | +18 | +0.6% | 169,200 |
2016/04/25 | 2,935 | 2,935 | 2,881 | 2,895 | -28 | -1% | 200,200 |
2016/04/22 | 2,926 | 2,935 | 2,889 | 2,923 | -16 | -0.5% | 265,400 |
2016/04/21 | 2,961 | 2,977 | 2,922 | 2,939 | +23 | +0.8% | 226,600 |
2016/04/20 | 2,918 | 2,966 | 2,883 | 2,916 | +4 | +0.1% | 452,900 |
2016/04/19 | 2,901 | 2,933 | 2,877 | 2,912 | +54 | +1.9% | 221,600 |
2016/04/18 | 2,827 | 2,889 | 2,816 | 2,858 | -19 | -0.7% | 372,700 |
2016/04/15 | 2,833 | 2,908 | 2,819 | 2,877 | +1 | ±0% | 263,300 |
2016/04/14 | 2,841 | 2,880 | 2,804 | 2,876 | +69 | +2.5% | 288,900 |
2016/04/13 | 2,791 | 2,825 | 2,763 | 2,807 | +22 | +0.8% | 268,900 |
2016/04/12 | 2,790 | 2,804 | 2,764 | 2,785 | +28 | +1% | 349,400 |
2016/04/11 | 2,703 | 2,766 | 2,690 | 2,757 | +41 | +1.5% | 269,300 |
2016/04/08 | 2,631 | 2,737 | 2,620 | 2,716 | +35 | +1.3% | 325,500 |
2016/04/07 | 2,641 | 2,690 | 2,614 | 2,681 | +46 | +1.7% | 337,900 |
2016/04/06 | 2,596 | 2,640 | 2,578 | 2,635 | +38 | +1.5% | 325,500 |
2016/04/05 | 2,633 | 2,685 | 2,593 | 2,597 | -21 | -0.8% | 288,900 |
2016/04/04 | 2,612 | 2,666 | 2,600 | 2,618 | +18 | +0.7% | 209,200 |
2016/04/01 | 2,699 | 2,702 | 2,596 | 2,600 | -102 | -3.8% | 280,800 |
2016/03/31 | 2,774 | 2,778 | 2,702 | 2,702 | -72 | -2.6% | 253,700 |
2016/03/30 | 2,796 | 2,815 | 2,771 | 2,774 | -25 | -0.9% | 237,800 |
2016/03/29 | 2,805 | 2,835 | 2,793 | 2,799 | -37 | -1.3% | 258,400 |
2016/03/28 | 2,797 | 2,837 | 2,796 | 2,836 | +89 | +3.2% | 284,200 |
2016/03/25 | 2,773 | 2,776 | 2,737 | 2,747 | -18 | -0.7% | 234,000 |
2016/03/24 | 2,753 | 2,792 | 2,753 | 2,765 | +12 | +0.4% | 264,500 |
2016/03/23 | 2,740 | 2,781 | 2,731 | 2,753 | +22 | +0.8% | 180,800 |
2016/03/22 | 2,713 | 2,739 | 2,681 | 2,731 | +60 | +2.2% | 422,000 |
2016/03/18 | 2,719 | 2,732 | 2,645 | 2,671 | -62 | -2.3% | 594,400 |
2016/03/17 | 2,750 | 2,756 | 2,715 | 2,733 | -4 | -0.1% | 335,300 |
2016/03/16 | 2,724 | 2,756 | 2,703 | 2,737 | +9 | +0.3% | 252,500 |
2016/03/15 | 2,722 | 2,750 | 2,715 | 2,728 | -13 | -0.5% | 251,900 |
2016/03/14 | 2,766 | 2,770 | 2,721 | 2,741 | +3 | +0.1% | 294,000 |
2016/03/11 | 2,694 | 2,773 | 2,691 | 2,738 | +28 | +1% | 475,900 |
2016/03/10 | 2,689 | 2,737 | 2,689 | 2,710 | +30 | +1.1% | 371,200 |
2016/03/09 | 2,769 | 2,777 | 2,667 | 2,680 | -134 | -4.8% | 787,800 |
2016/03/08 | 2,881 | 2,904 | 2,800 | 2,814 | -63 | -2.2% | 237,400 |
2016/03/07 | 2,883 | 2,926 | 2,849 | 2,877 | -23 | -0.8% | 216,900 |
2016/03/04 | 2,936 | 2,950 | 2,843 | 2,900 | -36 | -1.2% | 537,900 |
2016/03/03 | 2,901 | 2,939 | 2,867 | 2,936 | ±0 | ±0% | 362,400 |
2016/03/02 | 2,880 | 2,952 | 2,854 | 2,936 | +88 | +3.1% | 327,500 |
2016/03/01 | 2,848 | 2,866 | 2,811 | 2,848 | -12 | -0.4% | 657,100 |
2016/02/29 | 2,921 | 2,921 | 2,856 | 2,860 | -18 | -0.6% | 227,300 |
2016/02/26 | 2,900 | 2,920 | 2,871 | 2,878 | -10 | -0.3% | 408,000 |
2016/02/25 | 2,826 | 2,892 | 2,824 | 2,888 | +80 | +2.8% | 384,700 |
2016/02/24 | 2,785 | 2,844 | 2,762 | 2,808 | +21 | +0.8% | 366,500 |
2016/02/23 | 2,842 | 2,850 | 2,768 | 2,787 | -6 | -0.2% | 309,500 |
2201~
2250
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 434,700円 | +20.9% | +87.3% | 3.13% | 9.71倍 | 1.12倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
住友ファーマ | 96,400円 | +26.8% | - | 0.00% | 16.23倍 | 3.35倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 436,500円 | +5.8% | +1.2% | 2.75% | 14.48倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 191,600円 | +5.0% | +1.5% | 0.00% | 16.45倍 | 4.38倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 336,300円 | +8.0% | -15.3% | 3.69% | 9.44倍 | 0.92倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム